top of page
MedMira receives Health Canada approval for its Multiplo® Rapid (TP/HIV) Test for Syphilis and HIV
Halifax, Nova Scotia - December 24, 2024 – MedMira Inc. (MedMira) (TSXV: MIR) announced today that it has received today, on December 24,...
MedMira
Dec 24, 20245 min read
MedMira Announces the appointment of Vice President of Commercial Operations
Halifax, Nova Scotia, October 3, 2024  – Today, MedMira Inc. (MedMira) (TSXV: MIR) today announced the appointment of Nicole Crenshaw as...
MedMira
Oct 3, 20243 min read
Clinical Trials to get Underway with Multiplo® Complete Syphilis (TP/nTP) Antibody Test - A Potential Game Changer to Address Syphilis Health Crisis in Canada
Halifax, Nova Scotia, 13 August, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces it will conduct full clinical trials for its...
MedMira
Aug 13, 20245 min read
Miriad MultiLinx - One Test, More Answers
Introducing MedMira's latest product now available anywhere for Tissue and Eye Banks: Miriad MultiLinx: One Test, More Answers. The...
MedMira
Jun 12, 20241 min read
MedMira Announces the Hire of Vice President of Business Development
Halifax, Nova Scotia,30 April, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to announce the expansion of their...
MedMira
Apr 30, 20242 min read
Innovation made easy
With MedMira's patented RVF Technology, there are a myriad of possibilities: As an example, our latest custom made product for one of our...
MedMira
Apr 19, 20241 min read
bottom of page